GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests. GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient population: people with type 2 diabetes who suffer from pulmonary fibrosis months or years after infection with SARS-CoV-2, the virus that causes COVID-19.

• Ponto de atenção: agonists.
• Ponto de atenção: help.
• Ponto de atenção: people.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.